within Pharmacolibrary.Drugs.ATC.A;

model A10BX08
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.63,
    Cl             = 0.0007616666666666668,
    adminDuration  = 600,
    adminMass      = 10 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.0111,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.007166666666666667,
    Tlag           = 0
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>A10BX08</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Mitiglinide is a rapid-acting insulin secretagogue of the meglitinide class that stimulates insulin release from pancreatic beta cells. It is used primarily for the treatment of type 2 diabetes mellitus, particularly in Japan and certain Asian countries. It is not widely approved in the United States or Europe.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters following a single 10 mg oral dose in healthy adult male volunteers.</p><h4>References</h4><ol><li><p>Jin, L, &amp; Cao, Q (2012). Effect of gemfibrozil on the pharmacokinetics of mitiglinide in rats. <i>Arzneimittel-Forschung</i> 62(1) 40–45. DOI:<a href=&quot;https://doi.org/10.1055/s-0031-1295425&quot;>10.1055/s-0031-1295425</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/22331762/&quot;>https://pubmed.ncbi.nlm.nih.gov/22331762</a></p></li><li><p>Dornhorst, A (2001). Insulinotropic meglitinide analogues. <i>Lancet (London, England)</i> 358(9294) 1709–1716. DOI:<a href=&quot;https://doi.org/10.1016/S0140-6736(01)06715-0&quot;>10.1016/S0140-6736(01)06715-0</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/11728565/&quot;>https://pubmed.ncbi.nlm.nih.gov/11728565</a></p></li><li><p>Liu, S, et al., &amp; Ju, W (2017). Pharmacokinetic and pharmacodynamic modeling of oral mitiglinide on glucose lowering in healthy Chinese volunteers. <i>BMC pharmacology &amp; toxicology</i> 18(1) 54–None. DOI:<a href=&quot;https://doi.org/10.1186/s40360-017-0161-6&quot;>10.1186/s40360-017-0161-6</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/28676080/&quot;>https://pubmed.ncbi.nlm.nih.gov/28676080</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end A10BX08;
